Hebrew Rehabilitation Center

CLIA Laboratory Citation Details

2
Total Citations
7
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 22D0697025
Address 1200 Center Street, Roslindale, MA, 02131
City Roslindale
State MA
Zip Code02131
Phone(617) 363-8000

Citation History (2 surveys)

Survey - December 13, 2019

Survey Type: Special

Survey Event ID: MVI911

Deficiency Tags: D0000 D2087 D2016 D2094 D2096

Summary:

Summary Statement of Deficiencies D0000 A CLIA paper desk review of proficiency testing was conducted for the the Hebrew Rehabilitation Center laboratory pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. Based on evidence of unsuccessful proficiency testing performance for the blood gas pCO2 analyte, the following Condition level deficiency was deemed to be not met: Condition 42 CFR 493.803 - Proficiency Testing - Successful Participation. . D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on proficiency testing review for calendar year 2019 (three testing events), of the College of American Pathologists (CAP) proficiency testing results, the laboratory Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- failed to successfully participate (achieve a score of 80 percent or more) in a proficiency testing program for the blood gas pCO2 analyte as evidenced by the following: The laboratory achieved a score for Cell Identification of zero (0) percent for the second and third testing events of 2017 resulting in unsuccessful performance for the analyte. Refer to D2087 and D2096. . D2087 ROUTINE CHEMISTRY CFR(s): 493.841(a) Failure to attain a score of at least 80 percent of acceptable responses for each analyte in each testing event is unsatisfactory analyte performance for the testing event. This STANDARD is not met as evidenced by: Based on record review of calendar year 2019 proficiency testing results (three testing events), the laboratory failed to attain an overall testing event score of at least 80 percent leading to unsatisfactory performance. Findings showed that for the blood gas pCO2 analyte the laboratory received a testing event score of sixty (60) percent for the first testing event of 2019 and the third testing event of 2019 leading to unsatisfactory performance for each of the two testing events. . D2094 ROUTINE CHEMISTRY CFR(s): 493.841(e) (1) For any unsatisfactory analyte or test performance or testing event for reasons other than a failure to participate, the laboratory must undertake appropriate training and employ the technical assistance necessary to correct problems associated with a proficiency testing failure. (2) For any unacceptable analyte or testing event score, remedial action must be taken and documented, and the documentation must be maintained by the laboratory for two years from the date of participation in the proficiency testing event. This STANDARD is not met as evidenced by: Based on proficiency testing record review, the laboratory failed to ensure that appropriate remedial action was taken in response to unacceptable analyte scores as evidenced by the following: A review of proficiency testing results for calendar year 2019 (three testing events) revealed that the laboratory obtained unacceptable analyte scores (scores of less than 80% for each parameter) for the blood gas pCO2 analyte for the first and third testing events of 2019 resulting in unsuccessful performance for the analyte (refer to D2016). Based on the second unacceptable proficiency testing result for the blood gas pCO2 analyte, there was no assurance that the laboratory had undertaken the appropriate training and employed the technical assistance necessary to correct the problem of unsuccessful proficiency testing performance for the blood gas pCO2 analyte. . D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) Failure to achieve satisfactory performance for the same analyte or test in two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. -- 2 of 3 -- This STANDARD is not met as evidenced by: Based on proficiency testing review for calendar year 2019 (three testing events), the laboratory failed to achieve satisfactory performance for the blood gas pCO2 analyte. The laboratory achieved a score of sixty (60) percent for blood gas pCO2 for the first and third testing events of 2019 resulting in unsuccessful performance. Refer to D2016. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 8, 2019

Survey Type: Standard

Survey Event ID: E83X11

Deficiency Tags: D0000 D2015

Summary:

Summary Statement of Deficiencies D0000 A CLIA recertification survey was conducted for the Hebrew Rehabilitation Center laboratory pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. D2015 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(5)(6) (5) The laboratory must document the handling, preparation, processing, examination, and each step in the testing and reporting of results for all proficiency testing samples. The laboratory must maintain a copy of all records, including a copy of the proficiency testing program report forms used by the laboratory to record proficiency testing results including the attestation statement provided by the PT program, signed by the analyst and the laboratory director, documenting that proficiency testing samples were tested in the same manner as patient specimens, for a minimum of two years from the date of the proficiency testing event. (6) PT is required for only the test system, assay, or examination used as the primary method for patient testing during the PT event. This STANDARD is not met as evidenced by: Based on proficiency testing (PT) record review and interview on 10/8/19, the laboratory did not maintain a copy of all proficiency testing records as evidenced by the following: A review of College of American Proficiency (CAP) PT records for calendar years 2019, 2018, and the third event in 2017 revealed that a signed attestation statement provided by the PT program, signed by the analyst and the laboratory director, was not maintained for the following testing events: Critical Care Blood Gas: 2018 Event C, 2019 Events A & B General Chemistry-Comprehensive: 2019 Event A Coagulation-Basic: 2019 Event A Clinical Microscopy Miscellaneous Photopage: 2019 Event A Hematology Automated Differential: 2019 Events A & B The technical consultant (TC) interviewed on 10/8/19 at 3:45 PM confirmed that attestation statements provided by the PT program were not signed by the analyst and Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- the laboratory director, documenting that proficiency testing samples were tested in the same manner as patient specimens. The TC stated that the attestations were on the CAP website. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access